 |
 |
 |
 |
 |
 |
 |
|
 |
 |
Leadership TeamGenstruct has assembled an impressive list of industry leaders to manage the company. Our leadership team hails from both top tier pharmaceutical companies as well as successful entrepreneurial organizations, and boasts a combined experience of nearly 100 years.Keith O. Elliston, Ph.D. - Co-Founder, President and Chief Executive Officer Christopher Z. Thomajan - Chief Financial Officer William M. Ladd, Ph.D. - S.V.P., Technology Platform & Operations Christian Reich, M.D., Ph.D. - V.P., Scientific Research Dexter Pratt - V.P., Knowledge Modeling Michelle Gordon-Savenor - Sr. Dir., Scientific Consulting & Alliance Mgmt Navin Chandra, Sc.D. (1960-2004) - Co-Founder and Chief Technology Officer  Co-Founder, President and Chief Executive Officer Keith Elliston is an experienced entrepreneur and intrapreneur who has dedicated his career to the development of leading-edge technology for drug discovery. Dr. Elliston spent over 10 years with Merck Research Laboratories, where he served as the director of bioinformatics, and the scientific director of the Merck Gene Index project. He then joined Bayer Pharmaceuticals where he founded their global genomics and bioinformatics efforts, and was the section head of Genomics and the worldwide head of Bioinformatics. In 1997, Dr. Elliston joined Gene Logic as chief scientific officer and pioneered the development and application of molecular profiling to drug discovery. He was responsible for the development and management of six pharmaceutical research partnerships representing over $350 million in potential revenues. In 1999, Dr. Elliston founded Viaken Systems, where he was chairman, president and CEO. Dr. Elliston has been an advisor to Oak Investment Partners, Atlas Ventures and other biotechnology venture capital groups, and has participated in the early stage development of a number of successful biotech companies. Dr. Elliston received an M.S. in genetics from the University of Minnesota, and a Ph.D. in molecular genetics from Rutgers University. to top  Chief Financial Officer Mr. Thomajan has 18 years of experience in a variety of industries, including Biotechnology, Investment Banking, Software, Internet Services, and Telecomm. He has extensive experience in raising debt and equity, has been involved in numerous M&A transactions, and has managed the Operations of several start-up companies during rapid revenue growth. He was a Founding Partner of America’s Growth Capital, a boutique investment bank focused on emerging growth technology companies, and was the early stage CFO/VP Operations for Asurion Corporation which has grown to over $1 billion in revenues. He was also the CFO for a pioneering Internet company, Delphi Internet Services, which was acquired by News Corporation in 1993. Mr. Thomajan received a B.A. from Dartmouth College and an M.B.A. from Columbia University. to top  S.V.P., Technology Platform & Operations Bill Ladd has over 18 years experience in the pharmaceutical and biotechnology industries, primarily in the areas of statistics and bioinformatics. Prior to joining Genstruct, Dr. Ladd led Analytic and Life Science Product Strategy as senior director of Analytic Applications at Spotfire. Earlier in his career, Dr. Ladd was the director of Bioinformatics Methods at Gene Logic and led the statistical analysis efforts of the Biological Data department at Merck. Dr. Ladd’s earned his Ph.D. in statistics with an emphasis in biostatistics from the University of Wisconsin. He holds an M.S. in statistics from Rutgers University and a B.S.E. in chemical engineering from Princeton University. Dr. Ladd's work has been published in a wide range of scientific journals. to top  V.P., Scientific Research Christian Reich has more than 15 years of experience in life science research and medicine. In his position as vice president of Scientific Research, Dr. Reich leads Genstruct’s internal biology research teams as well as efforts in translational medicine and clinical research with its large pharmaceutical partners. Dr. Reich was a practicing physician in Berlin and Ulm, Germany before moving to the European Bioinformatics Institute to work on the Human Genome Project. Dr. Reich joined Millennium Pharmaceuticals in 1998, where he was responsible for a number of key programs, including Millennium’s pathways initiative. Prior to joining Genstruct, he was the head of Clinical Informatics at Millennium, where he was involved in the areas of drug development, safety, clinical research and clinical trial management. Dr. Reich received his bachelor’s degree in preclinical training from Humboldt University in Berlin and holds an M.D. and Ph.D. from the Medical University of Lübeck where he focused research on T-cell activation and regulation. to top  V.P., Knowledge Modeling Dexter Pratt began consulting for Genstruct in 2002, and joined the company as its director of Biological Systems Modeling in 2003. While with Genstruct, Mr. Pratt has served as a technical team leader, software developer and platform architect, while also performing as biology project leader, team member and principal investigator for Genstruct’s internal and partnered projects. Mr. Pratt has an extremely strong background in artificial intelligence. He was a member of the research staff at the M.I.T. Artificial Intelligence Laboratory, where he worked on the team developing LISP hardware prototypes. In 1981, he joined LISP Machine, Inc., where he became the director of the User Interface Group and participated in the design and implementation of both hardware and software, including the development of a 1,000 chip LISP processor. In 1989, Mr. Pratt joined the CYC project, where he spent seven years developing novel knowledge representation systems and inference mechanisms for a groundbreaking, large-scale common sense reasoning system. Mr. Pratt has extensive startup experience, having served as the CTO for two internet media companies: Webkick and CineMetrix, where he was the technical architect of their respective platforms. Mr. Pratt received his undergraduate degree in chemistry from Yale University. to top  Sr. Dir., Scientific Consulting & Alliance Mgmt Michelle Gordon-Savenor is a leading alliance manager with strong experience leading alliances for large-scale biopharma collaboration efforts. Prior to Genstruct, Ms. Gordon-Savenor was an alliance manager for Millennium Pharmaceuticals, Inc. where she managed multi-year alliances with Monsanto and Aventis. At Millennium, she also held positions as a technical specialist and research associate. During her tenure at Millennium, Ms. Gordon-Savenor was a visiting scholar at the Whitehead Institute for Biological Research as part of the Affymetrix, BMS and Millennium Consortium. She began her career as a research technician at Beth Israel Hospital and subsequently as a research assistant at the New England Medical Center. Ms. Gordon-Savenor has been a speaker at industry events and has had papers published in Molecular Pharmacology, Proceedings of the National Academy of Science and the Journal of Immunology. She earned her A.B. degree in biology and English from Vassar College in Poughkeepsie, N.Y., and was a visiting student at the M.I.T. Sloan School of Management. to top  Co-Founder and Chief Technology Officer Navin Chandra was an artificial intelligence technology pioneer, educator and entrepreneur. He was an inventor on numerous technology patents, and his research have resulted in several widely cited publications and a book entitled Exploration and Innovation in Design now a classic in the AI in Design field. After receiving his doctorate from MIT in the 1980's, Dr. Chandra joined the faculty at Carnegie Mellon University in Computer Science as well as Civil Engineering. In 1993, he joined IndustryNet as director of Internet Commerce. In 1997, he transitioned to Time0, a business unit of Perot Systems, where he was responsible for a large government grant for information integration that yielded a number of key technologies he commercialized. Dr. Chandra subsequently started SkyIron Services, a company designed to help small businesses through web based business services and knowledge networks. With the turn of the millennium, Dr. Chandra saw the opportunity to apply his artificial intelligence and systems design expertise to biology. His vision for combining case-based reasoning and frame-based knowledge representations for biology were realized with the launch of Genstruct. As CTO, he designed and oversaw the initial development of Genstruct's platform, which enables scientists to identify mechanisms in biological systems using causal modeling. Dr. Chandra passed away on January 29th, 2004, but his innovative spirit and determination will continue to be part of Genstruct's future. to top |
 |
|
 |
| One Alewife Center | Cambridge, MA 02140 | (617) 547-5421 | sitemap |